The invention relates to a method for providing negative pressure to a negative pressure wound therapy bandage.
Negative pressure wound therapy is one method that is used to treat certain wounds or sores on people. In general the treatment includes, a bandage being placed over a wound site, and connected to a pumping device. The pumping device provides suction, creating a negative pressure under the bandage at the wound site. Exudates and other materials are removed from the wound site, allowing the wound to heal faster than under ambient pressure.
The pumping device includes, amongst other things, a pump. Typically, a user selects (or otherwise enters) an appropriate therapeutic pressure on the pumping device that correlates to the specific negative pressure treatment for that patient. It is important that the pump and pumping device achieve the therapeutic pressure that is to be used in association with the negative pressure wound therapy quickly and correctly.
The speed at which the pump can achieve the therapeutic pressure is important because the speed can detrimentally effect the treatment. Moreover, the ability for the pump to recognize that the therapeutic pressure has been achieved is important to avoid applying too little or too much negative pressure. Thus, for a pump device, the speed and the accuracy at which it obtains the therapeutic pressure is an important characteristic.
In order to accurately and quickly achieve the therapeutic pressure, some pumps are left on continuously. In some devices this can be problematic. For example, some pumps can quickly achieve the therapeutic pressure; however, the pump and system tends to overshoot the therapeutic pressure value. This requires additional valves and other components that allow the pumping device to release negative pressure until the appropriate negative pressure is obtained.
Moreover, leaving the pump on continuously can act as a power drain, and for pumping devices that operate on batteries or other portable power sources, this can negatively impact the life time of the power source.
The present invention is directed to resolving these and other matters.
In one embodiment of the invention, the invention is directed towards a method for providing negative pressure to a negative pressure wound therapy bandage by providing a pumping device having a pump and setting a therapeutic negative pressure on the pumping device. The pumping device determines a target negative pressure associated with the therapeutic negative pressure and the target negative pressure is less than the therapeutic negative pressure (as discussed herein, “less than” means it is less negative, or a lower amount of a negative pressure, in other words, closer to zero). The pumping device is connected to a negative pressure wound therapy bandage. The target negative pressure is achieved by cycling the pump on and off to create a negative pressure in the negative pressure wound therapy bandage, obtaining a plurality of samples of the negative pressure in the negative pressure wound therapy bandage, each sample being obtained at a first set time interval, calculating an average of a predetermined number of consecutive samples, comparing the average to the target negative pressure, and, continuing to cycle the pump on and off until the average is greater than the target pressure.
The method may also include after cycling the pump on and off until the average of samples is greater than the target pressure after the complete off cycle, sampling the negative pressure in the negative pressure wound therapy bandage at a second set time interval greater than the first set time interval.
In another embodiment of the invention, the sampling of the negative pressure in the negative pressure wound therapy bandage at the second set time interval begins when the pump has been off for a predetermined amount of time.
The predetermined amount of time may be 300 milliseconds.
The second set time interval may be 1000 milliseconds and the first set time interval is 100 milliseconds.
In an embodiment, the cycling of the pump on and off to create negative pressure in the negative pressure wound therapy bandage on is performed by turning the pump on for 80 milliseconds and then turning the pump off for 80 milliseconds.
In some embodiments of the present invention, the therapeutic negative pressure is 125 mmHg and the target negative pressure is approximately 115 mmHg.
In some embodiments of the present invention, the therapeutic negative pressure is 90 mmHg and the target negative pressure is approximately 85 mmHg.
In some embodiments of the present invention, the therapeutic negative pressure is 60 mmHg and the target negative pressure is approximately 54 mmHg.
In some embodiments of the present invention, the therapeutic negative pressure is 40 mmHg and the target negative pressure is approximately 34 mmHg.
In another embodiment of the invention, the invention is for a method for providing negative pressure to a negative pressure wound therapy bandage by providing a pumping device having a pump and setting a therapeutic negative pressure on the pumping device. The pumping device determines a target negative pressure associated with the therapeutic negative pressure and the target negative pressure is less than the therapeutic negative pressure. The pumping device is connected to a negative pressure wound therapy bandage. The target negative pressure is achieved by cycling the pump on and off for a first predetermined amount of time to create a negative pressure in the negative pressure wound therapy bandage, obtaining a plurality of samples of the negative pressure in the negative pressure wound therapy bandage, each sample being obtained at a first set time interval, calculating an average of a predetermined number of consecutive samples, comparing the average to the target negative pressure, and, if the average is not greater than the target negative pressure, repeating the steps of cycling the pump on and off, obtaining a plurality of samples, calculating an average and comparing the average, until the average is greater than the target negative pressure.
In some embodiments the comparing of the average occurs at a rate faster than the rate of calculating the average.
In some embodiments, if the average is greater than the target negative pressure, the target negative pressure is maintained by obtaining a plurality of second samples of the negative pressure in the negative pressure wound therapy bandage at a second set time interval begin greater than the first time interval, and, comparing each second sample to the target negative pressure, and, repeating the steps of obtaining and comparing if a second sample is greater than the target negative pressure.
In some embodiments, if a second sample is not greater than the target negative pressure, the step of achieving the target negative pressure by: cycling the pump on and off; obtaining a plurality of samples; calculating an average; and, comparing the average until the average is greater than the target negative pressure, is repeated.
In the various embodiments of the present invention, the therapeutic negative pressure may be selected from the group consisting of: 40 mmHg; 60 mmHg; 90 mmHg; and, 125 mmHg.
An invention according to one or more of the disclosed embodiments allows the pump to achieve the therapeutic negative pressure/target negative pressure reasonably quickly and limit exceeding the therapeutic negative pressure/target negative pressure as much as practical.
Moreover, at least one of the embodiments also provides a reliable method to detect when the bandage pressure was being “topped-up” too frequently due to a leak (i.e., often returning to cycle the pump on and off to increase negative pressure). It is expected that the system will leak a small amount over time, for example, due to the imperfect plumbing connections in the system. A leak rate of one “top-up” per minute is normal. However, a leak rate four times that is cause for a minor leak to be declared. Such a leak rate is still within the bounds of the system to handle long term but the user should be informed so that it is corrected and system battery life is extended. It is also desirable to clear the fault as soon as it appears that the leaking has returned to normal levels.
It is to be understood that the aspects and objects of the present invention described above may be combinable and that other advantages and aspects of the present invention will become apparent upon reading the following description of the drawings and detailed description of the invention.
The present invention will become more fully apparent from the following description and appended claims, taken in conjunction with the accompanying drawings. Understanding that the accompanying drawings depict only typical embodiments, and are, therefore, not to be considered to be limiting of the scope of the present disclosure, the embodiments will be described and explained with specificity and detail in reference to the accompanying drawings as provided below.
While this invention is susceptible of embodiment in many different forms, there is shown in the drawings and will herein be described in detail one or more embodiments with the understanding that the present disclosure is to be considered as an exemplification of the principles of the invention and is not intended to limit the invention to the embodiments illustrated.
Reference throughout this description to features, advantages, objects or similar language does not imply that all of the features and advantages that may be realized with the present invention should be or are in any single embodiment of the invention. Rather, language referring to the features and advantages is understood to mean that a specific feature, advantage, or characteristic described in connection with an embodiment is included in at least one embodiment of the present invention. Thus, discussion of the features and advantages, and similar language, throughout this specification may, but do not necessarily, refer to the same embodiment.
As shown in the attached
In order to provide negative pressure to a wound, the pumping device 10 is connected to a negative pressure wound therapy bandage 12, typically with tubing 14.
In order to achieve a target negative pressure the pumping device 10 turns the pump 20 on for short amounts of time when the pressure is below the target pressure.
The pump device 10 typically operates as follows: a microcontroller turns the pump 20 on via a digital output; the pump 20 starts producing a vacuum; the vacuum is converted to a voltage by a pressure sensor 22; the voltage is converted by an analog to digital converter (“the A/D”) to a standard, recognized pressure engineering unit; and, the microcontroller compares the monitored pressure to the target pressure.
In order to achieve the target negative pressure in a short amount of time and avoid overshooting the target negative pressure, the pump 20 is cycled. The duty cycle, the percentage of pump on time relative to pump off time, after examining several pumps in action, can be constant for a variety of pumps 20. How much vacuum the pump 20 can draw in a short time period will influence the pump on time. Moreover, bandage 14 and plumbing 28 elasticity and how quickly the pressure sensor 22 and the A/D can take a measurement will influence the pump off time.
In one embodiment, the pressure sensor 22 measurement time is 20 milliseconds; while the A/D measurement time is 16 microseconds. Therefore, since a change in pressure must first be converted by the pressure sensor 22 and then the A/D, the minimum measurement time is 20.016 milliseconds.
It is believed to be advantageous to average readings before they are used to mitigate occasional measurement system anomalies. The number of samples in the average, on the one hand, when it tends to be low, do some anomaly mitigation but also remain the most responsive to quick changes in the parameter they are measuring. The best anomaly mitigation appears to occur when the number of samples is high, but then the averaging is not very responsive to quick changes in the parameter they are measuring.
It was determined that it would be advantageous to use a sliding 5 sample average. If the pressure were sampled continuously, a complete average would be ready in: 5×20.016=100.090 milliseconds. However, it would not be necessary to wait for all 5 samples to be acquired before a pump control decision was made on the value because just a few samples still mitigates against system anomalies sufficiently. However, sampling the pressure continuously, especially since the pressure sensor 22 places the largest mA load of any component (other than the pump 20) on the system would unnecessarily shorten battery life for too little gain in pump control.
Consequently, a measurement process asynchronous to the pump on/off cycle was used wherein pressure samples are contributed to the average every 100 milliseconds, and if the pump on/off control logic compared the average every 80 milliseconds it would compare it often enough to determine an average affected by the very last contribution that was made to that average. This can be achieved by: starting the process every 100 milliseconds; waiting the 20 milliseconds pressure sensor measurement time; then, measuring the pressure with the A/D.
It is contemplated to synchronize the completion of the A/D measurement to the pump on/off control logic exactly but software design best practice says that dependencies between software modules should be avoided where possible and synchronization is not necessary here—the pump on/off control logic (cycle) will see every change any contribution makes to the average.
When the pump 20 has met its target pressure, the A/D sampling and comparing process detailed above changes from, for example, a repeat rate of 100 milliseconds to a repeat rate of 1000 milliseconds when the pump has been off for a sufficient amount of time. This further saves battery life at a time when the pressure is not likely to change very much. The period of time the pump 20 has to be off to switch to the slower repeat rate may be, for example, 300 milliseconds; however, it may be any value that was larger than the off period in the pump on/off duty cycle (more later on the duty cycle). Moreover, it should be at least that long to distinguish the “off” that is due to the pump 20 having reached the target pressure and the “off” of the pump control duty cycle. (The 300 milliseconds was utilized as it is a sufficient amount of time for the A/D to wait before it samples the battery voltage after the pump is turned off. The battery is only sampled when the pump 20 is turned off because the mA load that the pump places on the system is significantly different than when it is off and battery life is more easily predicted when the pump is not loading the system.)
The pump control on/off duty cycle is preferably 80 milliseconds on and 80 milliseconds off. It was determined that an “on” time of 40 or 80 milliseconds was sufficient for constraining the overshoot for a variety of bandages 12. The 40 milliseconds value constrained it better, yielded end pressures closer to the target pressure, but took longer to get to the target pressure. The “on” times longer than 80 milliseconds created out-of-bounds overshoot for some bandages—no matter what the “off” time was. As mentioned above, the “off” time has an effect on the measurement part of the control/measurement algorithm. Further, plumbing and bandage elasticity, although minor, can contort the average or “steady” pressure for a short while. It is believed that it is advantageous to let such pressure contortions settle before measurement. Moreover, the pressure sensor 22 and A/D measurements need time also as noted above.
An “off” time of approximately 30 milliseconds would cover both but it was convenient to use the same 80 milliseconds timer to control both the on time and the off time. Further, letting the system settle longer, for one or more multiples of the 80 milliseconds, would improve the quality of the measurement because it would let the sliding average fill more completely—at the cost of taking longer to get to the end pressure. While these times have been discussed, nothing herein should be construed to limit the present invention to these times.
In use, a user inputs the therapeutic negative pressure into the pumping device. Of course, this can be accomplished with the pumping device having pre-set therapeutic negative pressures and the user merely selects one.
In one or more embodiments of the present invention, a target negative pressure is set slightly less than the therapeutic negative pressure entered by the user into pumping device. In a working example of an embodiment of the invention, the following parameters were used with the object to obtain the therapeutic negative pressure of 40/60/90/125 mmHg within 15 seconds and limit overshoot to +/−10% of the therapeutic negative pressure. However, for the 40 mmHg therapeutic negative pressure, the tolerance is preferably +/−10 mmHg (not +/−10%).
Using a target negative pressure that is set slightly less than the 40/60/90/125 therapeutic negative pressure allows for compensation of the system's tendency to undervalue the actual negative pressure within the bandage. Therefore, the target pressures contemplated to be used with the previously mentioned therapeutic negative pressure values are 34, 54, 85 and 115 mmHg (respectively). Other target pressures can be used depending on the variety of parameters discussed above (pump, bandage, elasticity, etc.) without departing from the spirit of the present invention.
In a device according to one or more embodiments of the present invention, the pump 20 will reasonably quickly achieve the target negative pressure, stop, “top-up” once or twice after a few seconds and transition to the state where it only tops-up every minute or so to compensate for system leaking. The initial one or two top-ups are due to the pressure completely settling.
In sum, in one or more embodiments of the present invention, pressure is sampled every 100 ms; with the sampling by the pressure sensor and A/D taking 20.016 milliseconds. Samples go into a sliding 5 element average. The pumping device 10 asynchronously compares the average every 80 milliseconds s (slightly faster than the pressure is sampled). The pumping device 10 turns the pump 20 on for no more than one cycle (80 milliseconds) if pressure is below target pressure. After waiting one off cycle (80 milliseconds), if the pressure is still below the target pressure, the pump 20 is turned on again. These last two steps repeat until the pressure is greater than the target pressure, at which point the pump 20 is left off until the normal leaking in the system reduces the pressure below the target pressure. During the period when the pressure is above the target pressure, starting when the pump 20 has been continuously off for 300 milliseconds, sampling may be reduced to the 1000 milliseconds rate (to extend battery life).
A flow chart for performing the steps of some embodiments is shown in
At this point, the pumping device will begin to cycle the pump on and off 104. In addition, the pumping device will also begin sampling the pressure at the bandage 106. This sampling is preferably done at a set time. In
If, however, more than five samples have been collected 112, the pumping device will calculate the average of the last five samples taken 114. The pumping device will then compare the average of the last five samples to the target negative pressure 116. If the average of the last five samples is less than the target negative pressure 118, the pumping device will continue to sample the pressure at the bandage 106.
If the average of the last five samples is greater than the target pressure 120, the pumping device will cease the pump cycling. It is contemplated, although not required, that if the pump is in the middle of a cycle, that specific cycle be completed, before the pumping cycling is stopped. Alternatively, the pump cycling can be immediately stopped when the average is determined to be greater than the target negative pressure.
After the pump cycling has been stopped, the device begins sampling the pressure at the bandage 124. This sampling is conducted, preferably at a predetermined time interval, and as shown, occurs at “Timing B.” As previously mentioned, in order to increase the life of the batteries that may be powering the pumping device, it is preferred that Timing B is greater than Timing A.
Finally, the device continues to compare the sample of the pressure (taken in step 124) with the target negative pressure 126. If the most recent sample is greater than the target negative pressure 128, the device continues to sampling the pressure at the bandage 124.
If the most recent sample is less than the target pressure 130, the device may turn the pump on for one cycle 132, and continue to sample the pressure under the bandage 124. Alternatively, the device can return to cycling the pumping on and off 104 and the subsequent steps previously taken to achieve the target negative pressure.
In addition to achieving and maintaining negative pressure, one or more embodiments of the present invention also include a method for detecting a leak. For example, if the target negative pressure has been reached and at least 20 top-ups have occurred at the target negative pressure and the average of the last N (=3) top-up intervals is less than 15 seconds, a leak may be declared by the pump device. The minor leak detection may be cleared if the pump is disabled by the user or the top-up intervals are greater than or equal to 15 seconds.
The 15 seconds time value is related to an unacceptable leak rate (4 top-ups per minute) that was determined to be optimal. The pumping device records the time (since unit reset) of every top-up into a circular array of N elements and checks the top-up interval at every top-up or every 80 milliseconds, whichever occurs first. (The “or 80 milliseconds” facet is more useful for clearing the fault than declaring it.)
The time in the oldest of the array elements is subtracted from the current time and then divided by N to either yield the average of the last N top-ups (or what the average would have been if the 80 milliseconds timer tick that prompted the check was a top-up). An example of setting the fault and clearing the fault is given below:
The checks called due to the 80 milliseconds timer expiring are not shown in the above because they would have had no effect and their omission makes it easier to understand how the checks due to just the top-ups take place.
In the example above, the fault was cleared within 25 seconds of the last top-up, a fraction of three times the 15 seconds threshold (the threshold used to declare the fault). This is consistent with the goal of clearing the fault quickly if it appears as though the fault has been corrected. It could have been cleared even sooner, as fast as within 15 seconds, if the system time was compared to the newest recorded top-up instead of the oldest—but using more than one top-up time gives greater confidence that the fault has really been cleared.
It is to be understood that additional embodiments of the present invention described herein may be contemplated by one of ordinary skill in the art and that the scope of the present invention is not limited to the embodiments disclosed. While specific embodiments of the present invention have been illustrated and described, numerous modifications come to mind without significantly departing from the spirit of the invention, and the scope of protection is only limited by the scope of the accompanying claims.
This application is a continuation of U.S. patent application Ser. No. 13/299,783, filed Nov. 18, 2011, titled “METHOD FOR PROVIDING NEGATIVE PRESSURE TO A NEGATIVE PRESSURE WOUND THERAPY BANDAGE,” which claims priority to U.S. Provisional Application No. 61/490,118, filed May 26, 2011, titled “METHOD FOR PROVIDING NEGATIVE PRESSURE TO A NEGATIVE PRESSURE WOUND THERAPY BANDAGE.” The disclosure of each of these prior applications is hereby incorporated by reference in its entirety herein.
Number | Name | Date | Kind |
---|---|---|---|
695270 | Beringer | Mar 1902 | A |
1480562 | Mock | Jan 1924 | A |
2280915 | Johnson | Apr 1942 | A |
2367690 | Purdy | Jan 1945 | A |
2568933 | Robbins | Sep 1951 | A |
2632443 | Lesher | Mar 1953 | A |
2682873 | Evans et al. | Jul 1954 | A |
3367332 | Groves | Feb 1968 | A |
3486504 | Austin et al. | Dec 1969 | A |
3572340 | Lloyd et al. | Mar 1971 | A |
3610238 | Rich et al. | Oct 1971 | A |
3874387 | Barbieri | Apr 1975 | A |
3993080 | Loseff | Nov 1976 | A |
RE29319 | Nordby | Jul 1977 | E |
4062012 | Colbert et al. | Dec 1977 | A |
4102342 | Akiyama et al. | Jul 1978 | A |
4112947 | Nehring | Sep 1978 | A |
4136696 | Nehring | Jan 1979 | A |
4184510 | Murry et al. | Jan 1980 | A |
4217894 | Franetzki | Aug 1980 | A |
4219019 | Coates | Aug 1980 | A |
4224945 | Cohen | Sep 1980 | A |
4250882 | Adair | Feb 1981 | A |
4316466 | Babb | Feb 1982 | A |
4382441 | Svedman | May 1983 | A |
4465485 | Kashmer et al. | Aug 1984 | A |
4468227 | Jensen | Aug 1984 | A |
4525166 | Laclerc | Jun 1985 | A |
4534356 | Papadakis | Aug 1985 | A |
4551141 | McNeil | Nov 1985 | A |
4573965 | Russo | Mar 1986 | A |
4608041 | Nielsen | Aug 1986 | A |
4643641 | Clausen et al. | Feb 1987 | A |
4655766 | Theeuwes et al. | Apr 1987 | A |
4681562 | Beck et al. | Jul 1987 | A |
4710165 | McNeil et al. | Dec 1987 | A |
4778446 | Jensen | Oct 1988 | A |
4778456 | Lokken | Oct 1988 | A |
4792328 | Beck et al. | Dec 1988 | A |
4795435 | Steer | Jan 1989 | A |
4820284 | Hauri | Apr 1989 | A |
4921488 | Maitz et al. | May 1990 | A |
4936834 | Beck et al. | Jun 1990 | A |
4950483 | Ksander et al. | Aug 1990 | A |
4969880 | Zamierowski | Nov 1990 | A |
4972829 | Knerr | Nov 1990 | A |
4979944 | Luzsicza | Dec 1990 | A |
4994022 | Steffler et al. | Feb 1991 | A |
5055198 | Shettigar | Oct 1991 | A |
5056510 | Gilman | Oct 1991 | A |
5073172 | Fell | Dec 1991 | A |
5100396 | Zamierowski | Mar 1992 | A |
5127388 | Cicalese et al. | Jul 1992 | A |
5149331 | Ferdman et al. | Sep 1992 | A |
5152757 | Eriksson | Oct 1992 | A |
5167613 | Karami et al. | Dec 1992 | A |
5176663 | Svedman et al. | Jan 1993 | A |
5215519 | Shettigar | Jun 1993 | A |
5261893 | Zamierowski | Nov 1993 | A |
5266928 | Johnson | Nov 1993 | A |
5279608 | Cherif Cheikh | Jan 1994 | A |
5328614 | Matsumura | Jul 1994 | A |
5358494 | Svedman | Oct 1994 | A |
5380280 | Peterson | Jan 1995 | A |
5437651 | Todd et al. | Aug 1995 | A |
5445604 | Lang | Aug 1995 | A |
5489280 | Russell | Feb 1996 | A |
5498338 | Kruger et al. | Mar 1996 | A |
5527293 | Zamierowski | Jun 1996 | A |
5549584 | Gross | Aug 1996 | A |
5562107 | Lavender et al. | Oct 1996 | A |
5616121 | McKay | Apr 1997 | A |
5636643 | Argenta et al. | Jun 1997 | A |
5643189 | Masini | Jul 1997 | A |
5645081 | Argenta et al. | Jul 1997 | A |
5678564 | Lawrence et al. | Oct 1997 | A |
5733337 | Carr et al. | Mar 1998 | A |
5759570 | Arnold | Jun 1998 | A |
5785688 | Joshi et al. | Jul 1998 | A |
5830496 | Freeman | Nov 1998 | A |
5833646 | Masini | Nov 1998 | A |
5843011 | Lucas | Dec 1998 | A |
5857502 | Buchalter | Jan 1999 | A |
5868933 | Patrick et al. | Feb 1999 | A |
5876611 | Shettigar | Mar 1999 | A |
5964723 | Augustine | Oct 1999 | A |
6071267 | Zamierowski | Jun 2000 | A |
6103951 | Freeman | Aug 2000 | A |
6110197 | Augustine et al. | Aug 2000 | A |
6135116 | Vogel et al. | Oct 2000 | A |
D434150 | Turney et al. | Nov 2000 | S |
6142982 | Hunt et al. | Nov 2000 | A |
6168800 | Dobos et al. | Jan 2001 | B1 |
6176307 | Danos et al. | Jan 2001 | B1 |
6225523 | Masini | May 2001 | B1 |
6254567 | Treu et al. | Jul 2001 | B1 |
6255552 | Cummings et al. | Jul 2001 | B1 |
6261283 | Morgan et al. | Jul 2001 | B1 |
6287521 | Quay et al. | Sep 2001 | B1 |
6345623 | Heaton et al. | Feb 2002 | B1 |
6398767 | Fleischmann | Jun 2002 | B1 |
6402724 | Smith et al. | Jun 2002 | B1 |
6450773 | Upton | Sep 2002 | B1 |
6458109 | Henley et al. | Oct 2002 | B1 |
6465708 | Augustine | Oct 2002 | B1 |
6471685 | Johnson | Oct 2002 | B1 |
6471982 | Lydon et al. | Oct 2002 | B1 |
6482491 | Samuelsen et al. | Nov 2002 | B1 |
6491684 | Joshi et al. | Dec 2002 | B1 |
6553998 | Heaton et al. | Apr 2003 | B2 |
6599262 | Masini | Jul 2003 | B1 |
6648862 | Watson | Nov 2003 | B2 |
6673028 | Argenta et al. | Jan 2004 | B1 |
6676610 | Morton et al. | Jan 2004 | B2 |
6685681 | Lockwood et al. | Feb 2004 | B2 |
6695823 | Lina et al. | Feb 2004 | B1 |
6695824 | Howard et al. | Feb 2004 | B2 |
6752794 | Lockwood et al. | Jun 2004 | B2 |
6755807 | Risk, Jr. et al. | Jun 2004 | B2 |
6756903 | Omry et al. | Jun 2004 | B2 |
6764462 | Risk, Jr. et al. | Jul 2004 | B2 |
6767334 | Randolph | Jul 2004 | B1 |
6814079 | Heaton et al. | Nov 2004 | B2 |
6824533 | Risk, Jr. et al. | Nov 2004 | B2 |
6855135 | Lockwood et al. | Feb 2005 | B2 |
6856821 | Johnson | Feb 2005 | B2 |
6936037 | Bubb | Aug 2005 | B2 |
6951553 | Bubb et al. | Oct 2005 | B2 |
6977323 | Swenson | Dec 2005 | B1 |
6979324 | Bybordi et al. | Dec 2005 | B2 |
6994702 | Johnson | Feb 2006 | B1 |
7004915 | Boynton et al. | Feb 2006 | B2 |
7022113 | Lockwood et al. | Apr 2006 | B2 |
7067709 | Murata et al. | Jun 2006 | B2 |
7070584 | Johnson et al. | Jul 2006 | B2 |
7077832 | Fleischmann | Jul 2006 | B2 |
7087806 | Scheinberg et al. | Aug 2006 | B2 |
7108683 | Zamierowski | Sep 2006 | B2 |
7118545 | Boyde | Oct 2006 | B2 |
7128735 | Weston | Oct 2006 | B2 |
7195624 | Lockwood | Mar 2007 | B2 |
7214202 | Vogel et al. | May 2007 | B1 |
7216651 | Argenta et al. | May 2007 | B2 |
7361184 | Joshi | Apr 2008 | B2 |
7381859 | Hunt et al. | Jun 2008 | B2 |
7438705 | Karpowicz et al. | Oct 2008 | B2 |
7494482 | Orgill et al. | Feb 2009 | B2 |
7503910 | Adahan | Mar 2009 | B2 |
7524315 | Blott et al. | Apr 2009 | B2 |
7534240 | Johnson | May 2009 | B1 |
7534927 | Lockwood | May 2009 | B2 |
7569742 | Haggstrom | Aug 2009 | B2 |
7611500 | Lina et al. | Nov 2009 | B1 |
7612247 | Oyaski | Nov 2009 | B2 |
7615036 | Joshi | Nov 2009 | B2 |
7645253 | Gura et al. | Jan 2010 | B2 |
7645269 | Zamierowski | Jan 2010 | B2 |
7678090 | Risk, Jr. | Mar 2010 | B2 |
7699823 | Haggstrom | Apr 2010 | B2 |
7699830 | Martin | Apr 2010 | B2 |
7708724 | Weston | May 2010 | B2 |
7717313 | Criscuolo et al. | May 2010 | B2 |
7753894 | Blott et al. | Jul 2010 | B2 |
7759537 | Bishop et al. | Jul 2010 | B2 |
7759538 | Fleischmann | Jul 2010 | B2 |
7759539 | Shaw et al. | Jul 2010 | B2 |
7763000 | Risk, Jr. | Jul 2010 | B2 |
7775998 | Riesinger | Aug 2010 | B2 |
7776028 | Miller et al. | Aug 2010 | B2 |
7779625 | Joshi | Aug 2010 | B2 |
7790945 | Watson, Jr. | Sep 2010 | B1 |
7790946 | Mulligan | Sep 2010 | B2 |
7794438 | Henley | Sep 2010 | B2 |
7794450 | Blott et al. | Sep 2010 | B2 |
7811269 | Boynton | Oct 2010 | B2 |
7815616 | Boehringer et al. | Oct 2010 | B2 |
7825289 | Vess | Nov 2010 | B2 |
7828782 | Suzuki | Nov 2010 | B2 |
7838717 | Haggstrom | Nov 2010 | B2 |
7846141 | Weston | Dec 2010 | B2 |
7862339 | Mulligan | Jan 2011 | B2 |
7883494 | Martin | Feb 2011 | B2 |
7909805 | Weston | Mar 2011 | B2 |
7927319 | Lawhorn | Apr 2011 | B2 |
7959624 | Riesinger | Jun 2011 | B2 |
7964766 | Blott et al. | Jun 2011 | B2 |
7976519 | Bubb et al. | Jul 2011 | B2 |
7998125 | Weston | Aug 2011 | B2 |
8025052 | Matthews et al. | Sep 2011 | B2 |
8062272 | Weston | Nov 2011 | B2 |
8062273 | Weston | Nov 2011 | B2 |
8080702 | Blott et al. | Dec 2011 | B2 |
8100887 | Weston | Jan 2012 | B2 |
8105295 | Blott et al. | Jan 2012 | B2 |
8118794 | Weston | Feb 2012 | B2 |
8128615 | Blott | Mar 2012 | B2 |
8152785 | Vitaris | Apr 2012 | B2 |
8162907 | Heagle | Apr 2012 | B2 |
8162909 | Blott et al. | Apr 2012 | B2 |
8167869 | Wudyka | May 2012 | B2 |
8235955 | Blott et al. | Aug 2012 | B2 |
8241018 | Harr | Aug 2012 | B2 |
8282611 | Weston | Oct 2012 | B2 |
8294586 | Pidgeon et al. | Oct 2012 | B2 |
8303552 | Weston | Nov 2012 | B2 |
8308714 | Weston et al. | Nov 2012 | B2 |
8317774 | Adahan | Nov 2012 | B2 |
8323264 | Weston et al. | Dec 2012 | B2 |
8353857 | Rosenberg | Jan 2013 | B2 |
8366692 | Weston | Feb 2013 | B2 |
8377016 | Argenta et al. | Feb 2013 | B2 |
8398614 | Blott | Mar 2013 | B2 |
D679819 | Peron | Apr 2013 | S |
D679820 | Peron | Apr 2013 | S |
8444392 | Turner et al. | May 2013 | B2 |
8449509 | Weston | May 2013 | B2 |
8460255 | Joshi et al. | Jun 2013 | B2 |
8494349 | Gordon | Jul 2013 | B2 |
8617129 | Hartwell | Dec 2013 | B2 |
8641693 | Locke et al. | Feb 2014 | B2 |
8663198 | Buan et al. | Mar 2014 | B2 |
8663200 | Weston et al. | Mar 2014 | B2 |
8715256 | Greener | May 2014 | B2 |
8734425 | Nicolini | May 2014 | B2 |
8764732 | Hartwell | Jul 2014 | B2 |
8785059 | Hartwell | Jul 2014 | B2 |
8795243 | Weston | Aug 2014 | B2 |
8808259 | Walton et al. | Aug 2014 | B2 |
8808274 | Hartwell | Aug 2014 | B2 |
8814841 | Hartwell | Aug 2014 | B2 |
8834451 | Blott et al. | Sep 2014 | B2 |
8905985 | Allen et al. | Dec 2014 | B2 |
8945074 | Buan et al. | Feb 2015 | B2 |
8951235 | Allen et al. | Feb 2015 | B2 |
9084845 | Adie et al. | Jul 2015 | B2 |
20010016205 | Shimizu | Aug 2001 | A1 |
20010029956 | Argenta | Oct 2001 | A1 |
20010034499 | Sessions et al. | Oct 2001 | A1 |
20020065494 | Lockwood et al. | May 2002 | A1 |
20020068913 | Fleischmann | Jun 2002 | A1 |
20020115952 | Tumey | Aug 2002 | A1 |
20020120185 | Johnson | Aug 2002 | A1 |
20020143286 | Tumey | Oct 2002 | A1 |
20020150720 | Howard et al. | Oct 2002 | A1 |
20020161346 | Lockwood et al. NUM | Oct 2002 | A1 |
20020183702 | Henley et al. | Dec 2002 | A1 |
20020198503 | Risk et al. | Dec 2002 | A1 |
20020198504 | Risk et al. | Dec 2002 | A1 |
20030014022 | Lockwood et al. | Jan 2003 | A1 |
20030014025 | Allen et al. | Jan 2003 | A1 |
20030021775 | Freeman | Jan 2003 | A1 |
20030040687 | Boynton et al. | Feb 2003 | A1 |
20030050594 | Zamierowski | Mar 2003 | A1 |
20030088202 | Gilman | May 2003 | A1 |
20030097086 | Gura | May 2003 | A1 |
20030108587 | Orgill et al. | Jun 2003 | A1 |
20030125649 | McIntosh | Jul 2003 | A1 |
20030144619 | Augustine | Jul 2003 | A1 |
20030171675 | Rosenberg | Sep 2003 | A1 |
20030175798 | Raees et al. | Sep 2003 | A1 |
20030208149 | Coffey | Nov 2003 | A1 |
20030212357 | Pace | Nov 2003 | A1 |
20030212431 | Brady et al. | Nov 2003 | A1 |
20030225347 | Argenta et al. | Dec 2003 | A1 |
20040019342 | Nagasuna et al. | Jan 2004 | A1 |
20040030304 | Hunt et al. | Feb 2004 | A1 |
20040039391 | Argenta et al. | Feb 2004 | A1 |
20040039415 | Zamierowski | Feb 2004 | A1 |
20040054338 | Bybordi et al. | Mar 2004 | A1 |
20040064132 | Boehringer et al. | Apr 2004 | A1 |
20040118460 | Stinson | Jun 2004 | A1 |
20040122434 | Argenta et al. | Jun 2004 | A1 |
20040127834 | Sigurjonsson et al. | Jul 2004 | A1 |
20040127862 | Bubb et al. | Jul 2004 | A1 |
20040127863 | Bubb et al. | Jul 2004 | A1 |
20040167482 | Watson | Aug 2004 | A1 |
20040225208 | Johnson | Nov 2004 | A1 |
20040241214 | Kirkwood et al. | Dec 2004 | A1 |
20040249353 | Risk, Jr. | Dec 2004 | A1 |
20050004534 | Lockwood et al. | Jan 2005 | A1 |
20050010153 | Lockwood et al. | Jan 2005 | A1 |
20050020955 | Sanders et al. | Jan 2005 | A1 |
20050028828 | Heaton et al. | Feb 2005 | A1 |
20050033214 | Cantor | Feb 2005 | A1 |
20050058694 | Nielsen | Mar 2005 | A1 |
20050070835 | Joshi | Mar 2005 | A1 |
20050080372 | Nielsen et al. | Apr 2005 | A1 |
20050090787 | Risk, Jr. | Apr 2005 | A1 |
20050148913 | Weston | Jul 2005 | A1 |
20050222527 | Miller et al. | Oct 2005 | A1 |
20050261643 | Bybordi et al. | Nov 2005 | A1 |
20050267402 | Stewart et al. | Dec 2005 | A1 |
20060015087 | Risk, Jr. et al. | Jan 2006 | A1 |
20060025727 | Boehringer et al. | Feb 2006 | A1 |
20060029650 | Coffey | Feb 2006 | A1 |
20060041247 | Petrosenko et al. | Feb 2006 | A1 |
20060069365 | Sperl et al. | Mar 2006 | A1 |
20060079852 | Bubb et al. | Apr 2006 | A1 |
20060083623 | Higgins et al. | Apr 2006 | A1 |
20060100586 | Karpowicz et al. | May 2006 | A1 |
20060100594 | Adams et al. | May 2006 | A1 |
20060116620 | Oyaski | Jun 2006 | A1 |
20060129137 | Lockwood | Jun 2006 | A1 |
20060149170 | Boynton et al. | Jul 2006 | A1 |
20060282175 | Haines et al. | Dec 2006 | A1 |
20070005028 | Risk, Jr. | Jan 2007 | A1 |
20070010797 | Nishtala et al. | Jan 2007 | A1 |
20070032762 | Vogel | Feb 2007 | A1 |
20070038172 | Zamierowski | Feb 2007 | A1 |
20070055209 | Patel et al. | Mar 2007 | A1 |
20070118096 | Smith et al. | May 2007 | A1 |
20070141128 | Blott et al. | Jun 2007 | A1 |
20070167884 | Mangrum et al. | Jul 2007 | A1 |
20070179460 | Adahan | Aug 2007 | A1 |
20070185426 | Ambrosio et al. | Aug 2007 | A1 |
20070185463 | Mulligan | Aug 2007 | A1 |
20070219532 | Karpowicz et al. | Sep 2007 | A1 |
20070239139 | Weston | Oct 2007 | A1 |
20070265585 | Joshi et al. | Nov 2007 | A1 |
20070265586 | Joshi | Nov 2007 | A1 |
20080004549 | Anderson | Jan 2008 | A1 |
20080004559 | Riesinger | Jan 2008 | A1 |
20080039759 | Holm et al. | Feb 2008 | A1 |
20080077091 | Mulligan | Mar 2008 | A1 |
20080082059 | Fink | Apr 2008 | A1 |
20080108977 | Heaton et al. | May 2008 | A1 |
20080119802 | Riesinger | May 2008 | A1 |
20080167593 | Fleischmann | Jul 2008 | A1 |
20080183119 | Joshi | Jul 2008 | A1 |
20080188820 | Joshi | Aug 2008 | A1 |
20080208147 | Argenta et al. | Aug 2008 | A1 |
20080223378 | Henderson et al. | Sep 2008 | A1 |
20080269651 | Warlick et al. | Oct 2008 | A1 |
20080306407 | Taylor | Dec 2008 | A1 |
20080306456 | Riesinger | Dec 2008 | A1 |
20090005746 | Nielsen | Jan 2009 | A1 |
20090012441 | Mulligan | Jan 2009 | A1 |
20090030402 | Adahan | Jan 2009 | A1 |
20090036873 | Nielsen | Feb 2009 | A1 |
20090054855 | Blott et al. | Feb 2009 | A1 |
20090054856 | Mormino et al. | Feb 2009 | A1 |
20090069759 | Blott et al. | Mar 2009 | A1 |
20090105670 | Bentley et al. | Apr 2009 | A1 |
20090125004 | Shen | May 2009 | A1 |
20090131888 | Joshi | May 2009 | A1 |
20090177135 | Rogers et al. | Jul 2009 | A1 |
20090192499 | Weston et al. | Jul 2009 | A1 |
20090198201 | Adahan | Aug 2009 | A1 |
20090216170 | Robinson et al. | Aug 2009 | A1 |
20090221977 | Blott et al. | Sep 2009 | A1 |
20090227968 | Vess | Sep 2009 | A1 |
20090227969 | Jaeb | Sep 2009 | A1 |
20090234306 | Vitaris | Sep 2009 | A1 |
20090234307 | Vitaris | Sep 2009 | A1 |
20090234309 | Vitaris et al. | Sep 2009 | A1 |
20090240185 | Jaeb et al. | Sep 2009 | A1 |
20090240218 | Braga et al. | Sep 2009 | A1 |
20090254053 | Svensby | Oct 2009 | A1 |
20090254054 | Blott et al. | Oct 2009 | A1 |
20090264837 | Adahan | Oct 2009 | A1 |
20090270820 | Johnson | Oct 2009 | A1 |
20090270833 | DeBelser et al. | Oct 2009 | A1 |
20090292264 | Hudspeth et al. | Nov 2009 | A1 |
20090299251 | Buan | Dec 2009 | A1 |
20090299255 | Kazala, Jr. et al. | Dec 2009 | A1 |
20090299256 | Barta et al. | Dec 2009 | A1 |
20090299257 | Long et al. | Dec 2009 | A1 |
20090299306 | Buan | Dec 2009 | A1 |
20090299307 | Barta et al. | Dec 2009 | A1 |
20090299341 | Kazala, Jr. et al. | Dec 2009 | A1 |
20090299342 | Cavanaugh, II et al. | Dec 2009 | A1 |
20090306580 | Blott et al. | Dec 2009 | A1 |
20090312723 | Blott et al. | Dec 2009 | A1 |
20090312728 | Randolph et al. | Dec 2009 | A1 |
20090326487 | Vitaris | Dec 2009 | A1 |
20100010477 | Augustine et al. | Jan 2010 | A1 |
20100036334 | Heagle et al. | Feb 2010 | A1 |
20100036367 | Krohn | Feb 2010 | A1 |
20100042074 | Weston | Feb 2010 | A1 |
20100063483 | Adahan | Mar 2010 | A1 |
20100063484 | Heagle | Mar 2010 | A1 |
20100069858 | Olson | Mar 2010 | A1 |
20100069863 | Olson | Mar 2010 | A1 |
20100087767 | McNeil | Apr 2010 | A1 |
20100100063 | Joshi et al. | Apr 2010 | A1 |
20100100075 | Weston et al. | Apr 2010 | A1 |
20100106114 | Weston et al. | Apr 2010 | A1 |
20100121286 | Locke et al. | May 2010 | A1 |
20100122417 | Vrzalik et al. | May 2010 | A1 |
20100125258 | Coulthard et al. | May 2010 | A1 |
20100126484 | Skell et al. | May 2010 | A1 |
20100150991 | Bernstein | Jun 2010 | A1 |
20100160879 | Weston | Jun 2010 | A1 |
20100160880 | Weston | Jun 2010 | A1 |
20100185163 | Heagle | Jul 2010 | A1 |
20100185165 | Middleton | Jul 2010 | A1 |
20100207768 | Pidgeon | Aug 2010 | A1 |
20100249733 | Blott et al. | Sep 2010 | A9 |
20100268198 | Buan et al. | Oct 2010 | A1 |
20100274207 | Weston | Oct 2010 | A1 |
20100278518 | Gordon | Nov 2010 | A1 |
20100280468 | Haggstrom et al. | Nov 2010 | A1 |
20100286635 | Watson, Jr. | Nov 2010 | A1 |
20100286638 | Malhi | Nov 2010 | A1 |
20100298866 | Fischvogt | Nov 2010 | A1 |
20100305490 | Coulthard | Dec 2010 | A1 |
20100305524 | Vess et al. | Dec 2010 | A1 |
20100312575 | Witt | Dec 2010 | A1 |
20100318043 | Malhi et al. | Dec 2010 | A1 |
20100324510 | Andresen et al. | Dec 2010 | A1 |
20100324516 | Braga et al. | Dec 2010 | A1 |
20100325864 | Briones et al. | Dec 2010 | A1 |
20100331797 | Patel ET AL. | Dec 2010 | A1 |
20110004171 | Blott et al. | Jan 2011 | A1 |
20110004172 | Eckstein et al. | Jan 2011 | A1 |
20110008179 | Turner et al. | Jan 2011 | A1 |
20110009835 | Blott | Jan 2011 | A1 |
20110009838 | Greener | Jan 2011 | A1 |
20110015593 | Svedman | Jan 2011 | A1 |
20110028918 | Hartwell | Feb 2011 | A1 |
20110028921 | Hartwell | Feb 2011 | A1 |
20110034892 | Buan | Feb 2011 | A1 |
20110046584 | Haggstrom | Feb 2011 | A1 |
20110054421 | Hartwell | Mar 2011 | A1 |
20110054422 | Locke et al. | Mar 2011 | A1 |
20110054423 | Blott et al. | Mar 2011 | A1 |
20110071483 | Gordon et al. | Mar 2011 | A1 |
20110077605 | Karpowicz et al. | Mar 2011 | A1 |
20110087176 | Blott | Apr 2011 | A2 |
20110087178 | Weston | Apr 2011 | A2 |
20110087180 | Weston | Apr 2011 | A2 |
20110092927 | Wilkes et al. | Apr 2011 | A1 |
20110092958 | Jacobs | Apr 2011 | A1 |
20110105963 | Hu et al. | May 2011 | A1 |
20110106030 | Scholz | May 2011 | A1 |
20110112492 | Bharti et al. | May 2011 | A1 |
20110118683 | Weston | May 2011 | A1 |
20110130712 | Topaz | Jun 2011 | A1 |
20110172615 | Greener et al. | Jul 2011 | A2 |
20110190735 | Locke et al. | Aug 2011 | A1 |
20110202220 | Seta et al. | Aug 2011 | A1 |
20110230849 | Coulthard et al. | Sep 2011 | A1 |
20110251567 | Blott et al. | Oct 2011 | A1 |
20110257572 | Locke et al. | Oct 2011 | A1 |
20110275964 | Greener | Nov 2011 | A1 |
20110282309 | Adie et al. | Nov 2011 | A1 |
20120001762 | Turner et al. | Jan 2012 | A1 |
20120053538 | Blott et al. | Mar 2012 | A1 |
20120078539 | Vernon-Harcourt et al. | Mar 2012 | A1 |
20120109084 | Blott et al. | May 2012 | A1 |
20120130325 | Blott et al. | May 2012 | A1 |
20120136325 | Allen | May 2012 | A1 |
20120157942 | Weston | Jun 2012 | A1 |
20120165764 | Allen et al. | Jun 2012 | A1 |
20120197229 | Buan | Aug 2012 | A1 |
20120302975 | Buan et al. | Nov 2012 | A1 |
20120302978 | Buan et al. | Nov 2012 | A1 |
20130018338 | Weston et al. | Jan 2013 | A1 |
20130110058 | Adie et al. | May 2013 | A1 |
20130150813 | Gordon et al. | Jun 2013 | A1 |
20130150814 | Buan | Jun 2013 | A1 |
20130296816 | Greener | Nov 2013 | A1 |
20130331823 | Askem et al. | Dec 2013 | A1 |
20140018753 | Joshi et al. | Jan 2014 | A1 |
20140088528 | Hartwell | Mar 2014 | A1 |
20140107599 | Fink et al. | Apr 2014 | A1 |
20140121617 | Locke et al. | May 2014 | A1 |
20140163494 | Buan et al. | Jun 2014 | A1 |
20140257212 | Boynton et al. | Sep 2014 | A1 |
20140316356 | Nicolini | Oct 2014 | A1 |
20150025482 | Begin et al. | Jan 2015 | A1 |
Number | Date | Country |
---|---|---|
2198243 | Feb 1996 | CA |
2367460 | Oct 2000 | CA |
2390513 | May 2001 | CA |
2121688 | Jul 2001 | CA |
2408305 | Nov 2001 | CA |
2458285 | Mar 2003 | CA |
2157772 | Sep 2003 | CA |
2809828 | Sep 1978 | DE |
3 935 818 | May 1991 | DE |
4 012 232 | Oct 1991 | DE |
198 44 355 | Apr 2000 | DE |
0 020 662 | Jul 1984 | EP |
0 355 186 | Feb 1990 | EP |
0 777 504 | Oct 1998 | EP |
0 782 421 | Jul 1999 | EP |
1 897 569 | Aug 2002 | EP |
0 708 620 | May 2003 | EP |
1 088 569 | Aug 2003 | EP |
1 440 667 | Mar 2006 | EP |
1 284 777 | Apr 2006 | EP |
1 171 065 | Mar 2007 | EP |
1 476 217 | Mar 2008 | EP |
1 121 163 | Nov 2008 | EP |
2098257 | Sep 2009 | EP |
1163907 | Oct 1958 | FR |
114754 | Apr 1918 | GB |
641061 | Aug 1950 | GB |
1224009 | Mar 1971 | GB |
1549756 | Aug 1979 | GB |
2195255 | Apr 1988 | GB |
2378392 | Feb 2003 | GB |
2415908 | Jan 2006 | GB |
2003-165843 | Jun 2003 | JP |
2010-504805 | Feb 2010 | JP |
2002-517288 | Jun 2010 | JP |
2010-531698 | Sep 2010 | JP |
1251912 | Apr 1983 | SU |
WO 198401904 | May 1984 | WO |
WO 199011795 | Oct 1990 | WO |
WO 199100718 | Jan 1991 | WO |
WO 199220299 | Nov 1992 | WO |
WO 199605873 | Feb 1996 | WO |
WO 199819068 | May 1998 | WO |
WO 199901173 | Jan 1999 | WO |
WO 1999064091 | Dec 1999 | WO |
WO 200007653 | Feb 2000 | WO |
WO 200050143 | Aug 2000 | WO |
WO 200059424 | Oct 2000 | WO |
WO 200119430 | Mar 2001 | WO |
WO 01037922 | May 2001 | WO |
WO 200134223 | May 2001 | WO |
WO 200185248 | Nov 2001 | WO |
WO 0193793 | Dec 2001 | WO |
WO 2002083046 | Oct 2002 | WO |
WO 2002092783 | Nov 2002 | WO |
WO 03045492 | Jun 2003 | WO |
WO 03057307 | Jul 2003 | WO |
WO 2003092620 | Nov 2003 | WO |
WO 2004024300 | Mar 2004 | WO |
WO 2004037334 | May 2004 | WO |
WO 2005025666 | Mar 2005 | WO |
WO 2005051461 | Jun 2005 | WO |
WO 2005070480 | Aug 2005 | WO |
WO 2005082435 | Sep 2005 | WO |
WO 2006046060 | May 2006 | WO |
WO 2008049029 | Oct 2006 | WO |
WO 07030601 | Mar 2007 | WO |
WO 2007024230 | Mar 2007 | WO |
WO 2007087811 | Aug 2007 | WO |
WO 2008039223 | Apr 2008 | WO |
WO 2008048481 | Apr 2008 | WO |
WO 2008100440 | Aug 2008 | WO |
WO 2008135997 | Nov 2008 | WO |
WO 2009004291 | Jan 2009 | WO |
WO 2009004371 | Jan 2009 | WO |
WO 2009019415 | Feb 2009 | WO |
WO 2009047524 | Apr 2009 | WO |
WO 09066105 | May 2009 | WO |
WO 09066106 | May 2009 | WO |
WO 2009089390 | Jul 2009 | WO |
WO 2010039481 | Apr 2010 | WO |
WO 2010051418 | May 2010 | WO |
WO 2010093753 | Aug 2010 | WO |
WO 2010121186 | Oct 2010 | WO |
WO 2010126444 | Nov 2010 | WO |
WO 2011023275 | Mar 2011 | WO |
WO 2011087871 | Oct 2011 | WO |
WO 2012022484 | Feb 2012 | WO |
WO 2012162370 | Nov 2012 | WO |
WO 2012162382 | Nov 2012 | WO |
WO 2012038724 | Mar 2013 | WO |
WO 2013140255 | Sep 2013 | WO |
WO 2013171585 | Nov 2013 | WO |
WO 2014151930 | Sep 2014 | WO |
Entry |
---|
US 6,306,115, 10/2001, Kelly et al. (withdrawn) |
Written Opinion of the International Searching Authority dated Sep. 6, 2012 in International Application No. PCT/US2012/039103 in 7 pages. |
International Search Report dated Sep. 6, 2012 in International Application No. PCT/US2012/039103 in 3 pages. |
U.S. Appl. No. 10/599,720, filed Oct. 6, 2006, Blott et al. |
U.S. Appl. No. 12/192,000, filed Aug. 14, 2008, Hartwell et al. |
U.S. Appl. No. 14/598,083, filed Jan. 15, 2015, Allen et al. |
U.S. Appl. No. 60/559,727, filed Apr. 5, 2004, Weston. |
U.S. Appl. No. 60/573,655, filed May 21, 2004, Weston. |
European Extended Search Report, re EP Application No. 12789546.4, dated Dec. 5, 2014. |
International Search Report dated Sep. 6, 2012 in International Application No. PCT/US2012/39103. |
International Preliminary Report on Patentability dated Nov. 26, 2013 in International Application No. PCT/US2012/39103. |
Achterberg, V., Ph.D., Hydroactive dressings and serum proteins: an in vitro study, Journal of Wound Care, February, vol. 5, No. 2, 1996 (pp. 79-82). |
Argenta, Louis C., et al., “Vacuum-Assisted Closure: A New Method for Wound Control and Treatment; Clinical Experience”, Ann Plas Surg 1997;38:563-577 (Dec. 10, 1996). |
Aubrey, D.A., et al., Treatment of the Perinea! Wound after Proctectomy by Intermittent Irrigation, Arch. Surg., Oct. 1984, 119, 1141-1144. |
Bagautdinov, N.A., “Variant of External Vacuum Aspiration in the Treatment of Purulent Diseases of Soft Tissues,” in current Problems in Modern Clinical Surgery: Interdepartmental Collection, edited by V. Ye. Volkov et al. (Chuvashia State University, Cheboksary, USSR 1986) pp. 94-96 (with English translation). |
Biblehimer, Helen L., “Dealing With a Wound that Drains 1.5 Liters a Day,” RN, Aug. 1986, pp. 21-23, USA. |
Bier, A., Hyperemia as a Therapeutic Agent, Ed. Dr. Gustavus M. Blech, A. Robertson & Co., Chicago 1905, pp. 74-85. |
Brubacher, “To Heal A Draining Wound”, RN Mar. 1982, 7 pages. |
Bucalo et al. “Inhibition of Cell Proliferation by Chronic Wound Fluid.” Wound Repair and Regeneration, Miami, 1993, pp. 181-186. |
Canadian Office Action for Canadian Application No. 2739605 dated Aug. 22, 2011 in 2 pages. |
Chariker, M.E., et al, “Effective Management of Incisional and Cutaneous Fistulae with Closed Suction Wound Drainage,” Contemporary Surgery. Jun. 1989, pp. 59-63, vol. 34 USA. |
Chinese Office Action dated Aug. 29, 2008 for Patent Application No. 200480032101.1, |
Chintamani, et al., “Half versus full vacuum suction drainage after modified radical mastectomy for breast cancer—a prospective randomized clinical trial”, Research Article (Jan. 27, 2005), 1-5. |
Costunchenok, BM, Effect of Vacuum on Surgical Purulent Wounds, Vestnik Chirurgia, 1986, 6 pages. |
Davydov et al. “Pathogenic Mechanisms of the Effect of Vacuum Therapy on the Course of the Wound Process” pp. 43-46 (Dec. 1990). |
Davydov, Yu A., et al., “Concepts for Clinical Biological Management of the Wound Process in the Treatment of Purulent Wounds Using Vacuum Therapy”, The Kremlin Papers: Perspectives in Wound Care, Russian Journal: Vestnik KhirurQii, BlueSky PublishinQ, La Costa, California (2004), 15-17. |
Davydov, Yu A., et al., “The Bacteriological and Cytological Assessment of Vacuum Therapy of Purulent Wounds”, The Kremlin Papers: Perspectives in Wound Care, Russian Journal: Vestnik KhirurQii, BlueSky PublishinQ, La Costa, California (2004), 11-14. |
Davydov, Yu A., et al., “Vacuum Therapy in the Treatment of Purulent Lactation Mastitis”, The Kremlin Papers: Perspectives in Wound Care, Russian Journal: Vestnik Khirurgii, BlueSky Publishing, La Costa, California (2004\, 5-7. |
De Lange, M.Y., et al., “Vacuum-Assisted Closure: Indications and Clinical Experience”, Eur J Plast Surg (2000) 2;178-182 (Feb. 9, 2000). |
Dilmaghani et al., “A Method for Closed Irrigation and Suction Therapy in Deep Wound Infections,” Journal of Bone and Joint Surgery, 1969, vol. 51-A, No. 2, pp. 323-342. |
EPO, Office Action for EP App. No. 04 791 592.1 dated Jun. 12, 2008. |
EPO, Second European Office Action for EP App. No. 04 791 592.1 dated Feb. 10, 2011. |
Fleischmann, Vacuum sealing: indication, technique, and results, European Journal of Orthopaedic Surgery & Traumatology (1995), pp. 37-40. |
Fleischmann, W. Wund Forum Spezial. IHW '94. “Vakuumversiegelung zur Behandlung von Problemwuden” (with English translation: Vacuum Sealing for Treatment of Problematical Wounds). |
Garcia-Rinaldi, R., et al., Improving the Efficiency of Wound Drainage Catheters, Amer. Journ. of Surg., Sep. 1975, pp. 130, 372-373. |
Hartz, R.S., et al., Healing of the Perinea! Wound, Arch. Surg., Apr. 1980, 115, 471-474. |
Health Technology, Literature R., “Vacuum Assisted Closure Therapy for Wound Care”, Health Technology Literature Review (Dec. 2004), 3-59. |
International Preliminary Report for International Application No. PCT/GB/2004/004549, dated Dec. 20, 2005. |
International Search Report for International Application No. PCT/GB/2004/004549, dated Feb. 21, 2005. |
Japanese Office Action dated Aug. 25, 2009 for Patent Application No. 2006-537411. |
Japanese Office Action dated Dec. 15, 2009 for Patent Application No. 2006-537411. |
Japanese Office Action dated Jun. 22, 2010 for Patent Application No. 2006-537411. |
Japanese Office Action dated Jan. 17, 2012 for Patent Application No. 2010-59188. |
Jeter, K.F., et al, “Managing Draining Wounds and Fistulae: New and Established Methods”, Chronic Wound Care, pp. 240-246. |
Johnson, F.E., An Improved Technique for Skin Graft Placement using a Suction Drain, Surgery, Gynecology and Obstetrics, Dec. 1984, 3 pages. |
KCI Inc., If It's Not VAC Therapy, It's Not Negative Pressure Wound Therapy, Jan. 2005. |
Khirugii, Vestnik, “A Collection of Published Studies Complementing the Research and Innovation of Wound Care”, The Kremlin Papers, Perspectives in Wound Care, Russian Medical Journal, Vestnik Khiruqii, Blue Sky Publishing (2004), 2-17. |
Kostiuchenok, B. M., et al., “The Vacuum Effect in the Surgical Treatment of Purulent Wounds”, The Kremlin Papers: Perspectives in Wound Care, Russian Journal: Vestnik Khirurgii, BlueSky Publishing, La Costa, California (2004), 3-4. |
Landes, R.R. and I. Melnick, An Improved Suction Device for Draining Wounds, Arch. Surg., May 1972, 104, p. 707. |
Linden, Willem van der, et al, “Randomized Trial of Drainage After Cholecystectomy: Suction Versus Static Drainage Through a Main Wound Versus a Stab Incision”, American Journal of Surgery, Feb. 1981, vol. 141, oo. 289-294. |
Mcfarlane, R.M., The Use of Continuous Suction under Skin Flaps, Br. Journ. Plast. Surg., pp. 77-86. |
Mclaughlan, J, et al, “Sterile Microenvironment for Postoperative Wound Care”, The Lancet, Sep. 2, 1978, pp. 503-504. |
Meyer, W. and V. Schmeiden, Bier's Hyperemic Treatment, Published 1908 W. B. Saunders Company, pp. 44-65. |
Morykwas, Michael J., et al., “Vacuum-Assisted Closure: A New Method for Wound Control and Treatment: Animal Studies and Basic Foundation”, Ann Plast Surg 1997;38:553-562 (Dec. 10, 1996). |
Nakayama, Y, et al, “A New Method for the Dressing of Free Skin Grafts”, Plastic and Reconstructive Surgery, Dec. 1990 pp. 1216-1219, UK. |
NURSING75, Wound Suction: Better Drainage with Fewer Problems, Nursing, vol. 5, No. 10, Oct. 1975, pp. 52-55. |
Office Action (Final) for U.S. Appl. No. 10/575,875, published as 2007/129,707, dated Jun. 17, 2009 in 19 pages. |
Ramirez, O.M., et al., Optimal Wound Healing under Op-Site Dressing, Ideas and Innovations, 73(3), pp. 474-475. |
Ranson, J. H. C., et al, “Safer Intraperitoneal Sump Drainage”, Surgery, Gynecology & Obstetrics, Nov. 1973, vol. 137, pp. 841-842. |
Sames, C.P., Sealing of Wounds with Vacuum Drainage, Br. Med. Journ., Nov. 5, 1977, p. 1223, Correspondence. |
Solovev, V. A., et al., “The Method of Treatment of Immature External Fistulas in the Upper Gastrointestinal Tract—Guidelines” USSR Ministry of Health, S. M. Kirov Gorky State Medical Institute, 1987 (with English translation). |
Solovev, V.A. “Treatment and Prevention of Suture Failures after Gastric Resection” (Dissertation Abstract) (S.M. Kirov Gorky State Medical Institute, Gorky USSR 1988). |
Stewart, Joanne, Ph.D., World Wide Wounds—Next generation of products for wound management—2002 (13 pages). |
Svedman, P., “Irrigation Treatment in Split-Thickness Skin Grafting of Intractable Leg Ulcers,” Scand J. Plast. Reconst. Surg., 19:211-213, 1985. |
Svedman, P., “Irrigation Treatment of Leg Ulcers,” The Lancet, Sep. 1983, 532-34. |
Svedman, P., A Dressing Allowing Continuous Treatment of a Biosurface, IRCS Med. Science: Biomed. Tech.; Clinic. Med.; Surg. and Transplantation, 1979, 7, p. 221. |
Svedman, P., et al., “A Dressing System Providing Fluid Supply and Suction Drainage Used for Continuous or Intermittent irrigation,” Annals of Plastic Surgery, vol. 17, No. 2, Aug. 1986, pp. 125-133. |
Swift, et al, “Quorum Sensing in Aeromonas hydrophila and Aeromonas salmoncida: Identification of LuxRI Homologs AhyRI and AsaRl and Their Cognate N-Acylhomoserine Lactone Signal Molecules,” J. Bacterial., 179(17):5271-5281 (1997). |
Teder and Svedman et al., “Continuous Wound Irrigation in the Pig,” Journal of Investigative Surgery, 1990, vol. 3, pp. 399-407. |
Tribble, David E. M.D., An Improved Sump Drain-Irrigation Device of Simple Construction, Archives of Surgery New York, pp. 511-13, 1972 vol. 105. |
Usupov, Y. N., et al., “Active Wound Drainage”, The Kremlin Papers: Perspectives in Wound Care, Russian Journal: Vestnik Khirurgii, BlueSky Publishing, La Costa, California (2004), 8-10. |
Venturi, Mark L., “Mechanisms and Clinical Applications of the Vacuum-Assisted Closure (VAC) Device”, Am J Clin Dermatol (2005) 693, 185-194; Review Article (2005),185-194. |
Vijanto, J. and J. Raekallio, Local Hyperalimentation of Open Wounds, Br. J. surg., 1976, 63, 427-430. |
Wackenfors, A., et al., Effects of Vacuum-Assisted Closure Therapy on Inguinal Wound Edge Microvascular Blood Flow, Wound Rep. Reg, 2004, 12, 600-606. |
Webb, New Techniques in Wound Management: Vacuum-Assisted Wound Closure, Journal of the American Academy of Orthopaedic Surgeons, v. 10, No. 5, pp. 303-311, Sep. 2002. |
Webster's Revised Unabridged Dictionary, published 1913 by C. & G. Merriam Co., definition of Flapper Valve, downloaded from Free Online Dictionary. |
Westaby, S., et al., “A Wound Irrigation Device”, The Lancet, Sep. 2, 1978, pp. 503-504. |
Wooding-Scott, Margaret, et al., “No Wound is Too Big for Resourceful Nurses,” RN Dec. 1988, pp. 22-25 USA. |
Wound Suction, Nursing, Oct. 1975, USA pp. 52-53. |
Wu, W.S., et al. Vacuum therapy as an intermediate phase in would closure: a clinical experience, Eur J Plast Surg (2000) 23: pp. 174-177. |
Office Action dated Jul. 17, 2015 received in Chinese Application No. 201280036812.0. |
Meyer, D. et al., “Weight-Loaded Syringes as a Simple and Cheap Alternative to Pumps for Vacuum-Enhanced Wound Healing”, Plastic and Reconstructive Surg., Jun. 2005, 2174-2176. |
Number | Date | Country | |
---|---|---|---|
20150352267 A1 | Dec 2015 | US |
Number | Date | Country | |
---|---|---|---|
61490118 | May 2011 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 13299783 | Nov 2011 | US |
Child | 14737387 | US |